Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
Following a radical prostatectomy and lymph node sampling, eligible patients will undergo
post-operative radiation therapy, concurrent weekly docetaxel chemotherapy , and hormonal
therapy (Casodex daily and Zoladex every 3 months for 2 times or Lupron 22.5 mg im every 3
months for 2 times).